Ignite Creation Date:
2024-05-06 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05227287
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-07
First Post:
2022-01-18
Brief Title:
ADH1 and ADH2 Disease Monitoring Study DMS
Sponsor:
Calcilytix Therapeutics Inc a BridgeBio company
Organization:
Calcilytix Therapeutics Inc a BridgeBio company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Autosomal Dominant Hypocalcemia |
Keywords:
| Name | View |
|---|---|
| Autosomal Dominant Hypocalcemia Type 1 ADH1 | View |
| Autosomal Dominant Hypocalcemia Type 2 ADH2 | View |
| Hypocalcemia | View |
| Musculoskeletal Diseases | View |
| Muscular Diseases | View |
| Musculoskeletal Abnormalities | View |
| Calcium Metabolism Disorders | View |
| Metabolic Diseases | View |
| Hypoparathyroidism | View |
| Hypocalcemic Seizures | View |
| Hypercalciuria | View |
| Nephrocalcinosis | View |
| Nephrolithiasis | View |
| Calcium Sensing Receptor | View |
| CaSR gene | View |
| CaSR gene mutation | View |
| CaSR mutation | View |
| GNA11 gene | View |
| GNA11 gene mutation | View |
| GNA11 mutation | View |